Simplex Trading
TGTX icon

Simplex Trading’s TG Therapeutics TGTX Stock Holding History

Simplex Trading’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.14M Buy
124,600
+40,100
+47% +$1.2M ﹤0.01% 1237
2025
Q4 		$2.52M Sell
84,500
-13,500
-14% -$441K ﹤0.01% 1795
2025
Q3 		$3.54M Sell
98,000
-114,300
-54% -$3.76M ﹤0.01% 1779
2025
Q2 		$7.64M Buy
212,300
+50,400
+31% +$1.88M ﹤0.01% 1055
2025
Q1 		$6.38M Sell
161,900
-51,900
-24% -$1.75M ﹤0.01% 1153
2024
Q4 		$6.43M Buy
213,800
+2,700
+1% +$77.5K ﹤0.01% 1299
2024
Q3 		$4.94M Buy
211,100
+13,000
+7% +$284K ﹤0.01% 1499
2024
Q2 		$3.52M Sell
198,100
-112,700
-36% -$1.8M ﹤0.01% 1690
2024
Q1 		$4.73M Sell
310,800
-23,300
-7% -$371K ﹤0.01% 1644
2023
Q4 		$5.71M Buy
334,100
+22,600
+7% +$263K ﹤0.01% 1454
2023
Q3 		$2.6M Sell
311,500
-100,300
-24% -$1.4M ﹤0.01% 1863
2023
Q2 		$10.2M Buy
411,800
+195,000
+90% +$5.04M 0.01% 878
2023
Q1 		$3.26M Sell
216,800
-313,500
-59% -$4.76M ﹤0.01% 1565
2022
Q4 		$6.27M Buy
530,300
+37,900
+8% +$275K 0.01% 1094
2022
Q3 		$2.92M Buy
492,400
+46,200
+10% +$303K ﹤0.01% 1639
2022
Q2 		$1.9M Buy
446,200
+243,500
+120% +$1.52M ﹤0.01% 1939
2022
Q1 		$1.93M Buy
202,700
+99,400
+96% +$1.15M ﹤0.01% 2150
2021
Q4 		$1.96M Buy
103,300
+54,100
+110% +$1.4M ﹤0.01% 2069
2021
Q3 		$1.99M Buy
49,200
+1,500
+3% +$46.4K ﹤0.01% 2144
2021
Q2 		$1.85M Buy
+47,700
New +$1.87M ﹤0.01% 2271
2021
Q1 		– Sell
-560
Closed -$2.91M – 10018
2020
Q4 		$2.91M Buy
560
+125
+29% +$4.22K ﹤0.01% 1412
2020
Q3 		$1.16M Sell
435
-1,236
-74% -$28.4K ﹤0.01% 2055
2020
Q2 		$3.25M Sell
1,671
-1,141
-41% -$18.4K 0.01% 1133
2020
Q1 		$2.77M Sell
2,812
-19
-0.7% -$240 ﹤0.01% 1042
2019
Q4 		$3.14M Buy
2,831
+1,679
+146% +$12.8K 0.01% 1119
2019
Q3 		$646K Sell
1,152
-923
-44% -$6.43K ﹤0.01% 2351
2019
Q2 		$1.79M Buy
2,075
+1,205
+139% +$9.11K ﹤0.01% 1390
2019
Q1 		$699K Sell
870
-487
-36% -$2.63K ﹤0.01% 2305
2018
Q4 		$556K Sell
1,357
-393
-22% -$1.95K ﹤0.01% 2118
2018
Q3 		$980K Buy
1,750
+637
+57% +$7.28K ﹤0.01% 1911
2018
Q2 		$1.46M Sell
1,113
-118,232
-99% -$1.63M 0.01% 1414
2018
Q1 		$1.91M Buy
119,345
+118,200
+10,323% +$1.51M 0.08% 199
2017
Q4 		$50K Buy
1,145
+395
+53% +$3.45K ﹤0.01% 2459
2017
Q3 		$94K Buy
750
+89
+13% +$1.01K ﹤0.01% 1761
2017
Q2 		$44K Buy
661
+29
+5% +$325 ﹤0.01% 2513
2017
Q1 		$60K Buy
+632
New +$4.54K ﹤0.01% 2202
2016
Q4 		– Sell
-11
Closed -$1K – 6516
2016
Q3 		$1K Buy
+11
New +$71 ﹤0.01% 5441
2015
Q4 		– Sell
-272
Closed -$10K – 6126
2015
Q3 		$10K Buy
272
+99
+57% +$1.48K ﹤0.01% 3461
2015
Q2 		$8K Sell
173
-190
-52% -$3.01K ﹤0.01% 3278
2015
Q1 		$39K Buy
363
+350
+2,692% +$5.3K ﹤0.01% 1758
2014
Q4 		$4K Buy
+13
New +$169 ﹤0.01% 3296

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Simplex Trading's TGTX Position: Q1 2026 in Review

Simplex Trading reduced its TG Therapeutics (TGTX) stake by 85% in Q1 2026, selling an estimated $1.04M and leaving 6,069 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #4286.

Simplex Trading first reported a position in TGTX in Q4 2014 and has held it in 38 quarters since. The position peaked at $5.42M in Q4 2024. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Simplex Trading held 6,069 shares of TG Therapeutics worth $202K as of Q1 2026.
  • Simplex Trading sold 34,973 TG Therapeutics shares in Q1 2026, an estimated $1.04M.
  • TG Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4286 holding.
  • Simplex Trading first reported a position in TG Therapeutics in Q4 2014 and has held it in 38 quarters since.
  • Simplex Trading's TG Therapeutics position peaked at $5.42M in Q4 2024.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.